{"prompt": "['2016N277425_03', 'CONFIDENTIAL', '2018N377698_00', '201749', '12.4.', 'Appendix 4: Definition of and Procedures for Recording,', 'Evaluating, Follow-Up and Reporting of Adverse Events', '12.4.1.', 'Definition of Adverse Events', 'Adverse Event Definition:', 'An AE is any untoward medical occurrence in a patient or clinical investigation', 'subject, temporally associated with the use of a medicinal product, whether or not', 'considered related to the medicinal product. Reporting Specific to Canada: For a', 'marketed medicinal product, this can also include failure to produce expected', 'benefits (i.e. lack of efficacy, with or without associated signs or symptoms or', 'clinical sequelae).', 'NOTE: An AE can therefore be any unfavorable and unintended sign (including an', 'abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally', 'associated with the use of a medicinal product.', 'Events meeting AE definition include:', 'Any abnormal laboratory test results (hematology, clinical chemistry, or urinalysis)', 'or other safety assessments (e.g., ECGs, radiological scans, vital signs', 'measurements), including those that worsen from baseline, and felt to be clinically', 'significant in the medical and scientific judgement of the investigator.', 'Exacerbation of a chronic or intermittent pre-existing condition including either an', 'increase in frequency and/or intensity of the condition.', 'New conditions detected or diagnosed after study treatment administration even', 'though it may have been present prior to the start of the study.', 'Signs, symptoms, or the clinical sequelae of a suspected interaction.', 'Signs, symptoms, or the clinical sequelae of a suspected overdose of either study', 'treatment or a concomitant medication (overdose per se will not be reported as an', 'AE/SAE unless this is an intentional overdose taken with possible suicidal/self-', 'harming intent. This should be reported regardless of sequelae).', 'Excluding Canada, \"Lack of efficacy\" or \"failure of expected pharmacological', 'action\" per se will not be reported as an AE or SAE. However, the signs and', 'symptoms and/or clinical sequelae resulting from lack of efficacy will be reported if', 'they fulfil the definition of an AE or SAE.', 'Reporting Specific to Canada: \"Lack of efficacy\" or \"failure of expected', 'pharmacological action\" will be reported as an AE or SAE as per the table below', '76']['2016N277425_03', 'CONFIDENTIAL', '2018N377698_00', '201749', 'Adverse', 'Electronic case record', 'Paper form only', 'Electronic case', 'Event', 'form (eCRF) only', 'record form', 'criteria', '(eCRF) + Paper', 'form', 'Non serious', 'Non drug related lack of', 'Drug related lack of', 'Drug related lack', 'efficacy reports with', 'efficacy reports', 'of efficacy with', 'associated signs or', 'without associated', 'associated signs or', 'symptoms or clinical', 'signs or symptoms or', 'symptoms or', 'sequelae', 'clinical sequelae.', 'clinical sequelae', 'Serious', 'Non drug related lack of', 'Drug related lack of', 'Drug related lack', 'efficacy reports with', 'efficacy reports', 'of efficacy reports', 'associated signs or', 'without associated', 'with associated', 'symptoms or clinical', 'signs or symptoms or', 'signs or symptoms', 'sequelae', 'clinical sequelae.', 'or clinical sequelae', 'Events NOT meeting definition of an AE include:', 'Any clinically significant abnormal laboratory findings or other abnormal safety', 'assessments which are associated with the underlying disease, unless judged by the', \"investigator to be more severe than expected for the subject's condition.\", 'The disease/disorder being studied or expected progression, signs, or symptoms of', \"the disease/disorder being studied, unless more severe than expected for the subject's\", 'condition.', 'Medical or surgical procedure (e.g., endoscopy, appendectomy): the condition that', 'leads to the procedure is an AE.', 'Situations where an untoward medical occurrence did not occur (social and/or', 'convenience admission to a hospital).', 'Anticipated day-to-day fluctuations of pre-existing disease(s) or condition(s) present', 'or detected at the start of the study that do not worsen.', '12.4.2.', 'Definition of Serious Adverse Events', 'If an event is not an AE per definition above, then it cannot be an SAE even if serious', 'conditions are met (e.g., hospitalization for signs/symptoms of the disease under study,', 'death due to progression of disease, etc).', 'Serious Adverse Event (SAE) is defined as any untoward medical occurrence that,', 'at any dose:', 'a.', 'Results in death', 'b. Is life-threatening', 'NOTE:', '77']\n\n###\n\n", "completion": "END"}